IP Library Granted Patent US 10,774,372
Granted Patent B2
US 10,774,372 · App. 16/596,200 · Granted Sep 15, 2020

Methods and systems for determining spatial patterns of biological targets in a sample

Inventors: Mark S. Chee (San Diego, CA); David A. Routenberg (San Diego, CA)
Assignee: Prognosy s Biosciences, Inc.
C12Q1/6809B01L3/5027
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,774,372
App. No.
16/596,200
Granted
Sep 15, 2020
Kind
B2
Abstract

The present disclosure provides methods and assay systems for use in spatially encoded biological assays, including assays to determine a spatial pattern of abundance, expression, and/or activity of one or more biological targets across multiple sites in a sample. In particular, the biological targets comprise proteins, and the methods and assay systems do not depend on imaging techniques for the spatial information of the targets. The present disclosure provides methods and assay systems capable of high levels of multiplexing where reagents are provided to a biological sample in order to address tag the sites to which reagents are delivered; instrumentation capable of controlled delivery of reagents; and a decoding scheme providing a readout that is digital in nature.

Claims (40)

1. A method of determining a location of a target polynucleotide in a sample comprising:

(a) attaching the sample affixed to a support to a first microfluidic device having multiple first addressing channels, wherein a first addressing channel identifies a first area in the sample;

(b) delivering a first probe through the first addressing channel to the first area in the sample, wherein the first probe comprises (i) a sequence substantially complementary to at least a portion of the target polynucleotide, (ii) a first address tag that identifies the first area in the sample, and (iii) a first ligation region;

(c) attaching the sample affixed to the support to a second microfluidic device having multiple second addressing channels, wherein a second addressing channel identifies in the sample a second area that intersects with the first area; and

(d) delivering a second probe through the second addressing channel to the second area in the sample, wherein the second probe comprises: (i) a second address tag that identifies the second area in the sample and (ii) a second ligation region, wherein the second probe is coupled to the first probe through ligation between the first and second ligation regions at an intersection between the first area and the second area, and the first and second address tags are used to identify the location of the target polynucleotide at the intersection in the sample.

2. The method of claim 1 , wherein the multiple first addressing channels are substantially parallel to each other and the multiple second addressing channels are substantially parallel to each other.

3. The method of claim 1 , wherein the multiple first addressing channels and/or the multiple second addressing channels is n addressing channels, wherein n is an integer between 20 and 1000.

4. The method of claim 1 , wherein the width of each of the multiple first addressing channels and/or each of the multiple second addressing channels is about 1 μm to about 500 μm.

5. The method of claim 1 , wherein the depth of each of the multiple first addressing channels and/or each of the multiple second addressing channels is about 1 μm to about 500 μm.

6. The method of claim 1 , wherein the distance between each of the multiple first addressing channels and/or between each of the multiple second addressing channels is about 1 μm to about 2.0 mm.

7. The method of claim 1 , wherein the second area forms an angle with the first area at the intersection, and wherein the angle is about 10 degrees to about 90 degrees.

8. The method of claim 1 , further comprising, between steps (b) and (c), allowing the first probe to hybridize with the target polynucleotide, and extending the first probe using the target polynucleotide as a template.

9. The method of claim 1 , wherein the second probe further comprises a variable tag region, a sequencing adaptor, or a combination thereof.

10. The method of claim 1 , wherein the second probe is coupled with the first probe by extension followed by ligation.

11. The method of claim 1 , wherein the sample is a freshly isolated tissue sample, a fixed tissue sample, a frozen tissue sample, an embedded tissue sample, a processed tissue sample, or a combination thereof.

12. The method of claim 1 , wherein the method further comprises determining the sequence of the first and second address tags by nucleic acid sequencing or high-throughput sequencing.

13. The method of claim 1 , wherein the target polynucleotide is an RNA.

14. The method of claim 13 , wherein the RNA is an mRNA.

15. A method of determining a location of a target protein in a sample comprising:

(a) delivering a first probe to the sample, wherein the first probe comprises: (i) a binding moiety that specifically binds to the target protein, and (ii) an oligonucleotide conjugated to the binding moiety;

(b) attaching the sample to a first microfluidic device having multiple first addressing channels, wherein a first addressing channel identifies a first area in the sample;

(c) delivering a second probe through the first addressing channel to the first area in the sample, wherein the second probe comprises: (i) a sequence substantially complementary to a portion of the sequence of the oligonucleotide of step (a), (ii) a sequence substantially complementary to a portion of a target polynucleotide, (iii) a first address tag that identifies the first area in the sample, and (iv) a first ligation region;

(d) attaching the sample from step (c) to a second microfluidic device having multiple second addressing channels, wherein a second addressing channel identifies in the sample a second area that intersects with the first area; and

(e) delivering a third probe through the second addressing channel to the second area in the sample, wherein the third probe comprises (i) a second address tag that identifies the second area in the sample, and (ii) a second ligation region, wherein the second probe is coupled with the third probe through ligation between the first and second ligation regions at an intersection between the first area and the second area, and the first and second address tags are used to identify the location of the target protein at the intersection in the sample.

16. The method of claim 15 , further comprising, between steps (c) and (d), extending the second probe using the oligonucleotide of step (a) as a template.

17. The method of claim 15 , wherein the third probe further comprises a variable tag region, a sequencing adaptor, or a combination thereof.

18. The method of claim 15 , wherein the target polynucleotide or a complement thereof encodes all or a portion of the target protein.

19. The method of claim 15 , wherein the target protein comprises an intracellular protein.

20. The method of claim 15 , wherein the target protein comprises an extracellular protein.

21. The method of claim 15 , wherein the binding moiety comprises an antibody or an antigen binding fragment thereof, an aptamer, a small molecule, an enzyme substrate, an affinity capture agent, or a combination thereof.

22. A method of determining a location of a target protein in a sample, comprising:

(a) delivering a first probe for the target protein to multiple locations in the sample, the first probe comprising (i) a binding moiety capable of specifically binding to the target protein, and (ii) an oligonucleotide conjugated to the binding moiety;

(b) delivering a second probe to a first location in the sample, wherein the second probe comprises: (i) a sequence substantially complementary to a portion of the sequence of the oligonucleotide of step (a), (ii) a sequence substantially complementary to at least a portion of a target polynucleotide; (iii) a first address tag that identifies the first location in the sample, and (iv) a first ligation region; and

(c) delivering a third probe to a second location in the sample, wherein the third probe comprises (i) a second address tag that identifies the second location in the sample to which the third probe is delivered, and (ii) a second ligation region, wherein the second probe is coupled with the third probe through ligation between the first and second ligation regions at an intersection between the first and second locations in the sample, and the first and second address tags are used to determine the location of the target protein at the intersection.

23. The method of claim 22 , comprising, between steps (b) and (c), extending the second probe using the oligonucleotide of step (a) as a template.

24. The method of claim 22 , wherein the third probe further comprises a variable tag region, a sequencing adaptor, or a combination thereof.

25. The method of claim 22 , wherein the target polynucleotide or a complement thereof encodes all or a portion of the target protein.

26. The method of claim 22 , wherein the target protein comprises an intracellular protein.

27. The method of claim 22 , wherein the target protein comprises an extracellular protein.

28. The method of claim 22 , wherein the binding moiety comprises an antibody or an antigen binding fragment thereof, an aptamer, a small molecule, an enzyme substrate, an affinity capture agent, or a combination thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 15, 2019
From: CHEE, MARK S.; ROUTENBERG, DAVID
To: PROGNOSYS BIOSCIENCES, INC.
Reel/Frame 050723/0816 →
Continuity (6)
Continuation 15831158 · Dec 4, 2017
Continuation 14900604
Continuation PCTUS2014044196 · Jun 25, 2014
Provisional Application 61839320 · Jun 25, 2013
Provisional Application 61839313 · Jun 25, 2013
Related Publication 20200109443A1 · Apr 9, 2020
Cited By (87)
US 12,188,085 US 12,188,087 US 12,195,790 US 12,203,134 US 12,203,136 US 12,209,273 US 12,209,280 US 12,215,379 US 12,223,751 US 12,227,796 US 12,228,544 US 12,234,505 US 12,234,507 US 12,241,060 US 12,241,890 US 12,249,085 US 12,258,624 US 12,264,358 US 12,265,079 US 12,270,071 US 12,270,074 US 12,270,077 US 12,275,984 US 12,275,988 US 12,281,357 US 12,286,673 US 12,287,264 US 12,297,486 US 12,297,487 US 12,297,488 US 12,297,499 US 12,319,956 US 12,325,877 US 12,331,347 US 12,344,892 US 12,360,105 US 12,365,935 US 12,365,942 US 12,365,944 US 12,371,688 US 12,378,607 US 12,385,083 US 12,391,979 US 12,391,980 US 12,391,984 US 12,399,123 US 12,400,733 US 12,404,544 US 12,405,264 US 12,416,603 US 12,435,363 US 12,435,364 US 12,442,045 US 12,460,251 US 12,467,086 US 12,497,653 US 12,497,654 US 12,498,378 US 12,508,590 US 12,509,717 US 12,516,369 US 12,529,094 US 12,529,096 US 12,545,949 US 12,553,079 US 12,553,805 US 12,553,898 US 12,559,790 US 12,559,791 US 12,565,671 US 12,566,113 US 12,566,114 US 12,571,029 US 12,618,099 US 12,624,475 US 12,637,706 US 12,662,699 US 12,668,793 US 12,668,835 US 12,674,196 US 12,687,494 US 12,692,484 US 12,692,492 US 12,703,879 US 12,709,771 US 12,716,092 US 12,718,518